Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
Keyword(s):
2019 ◽
Vol 38
(1)
◽
Keyword(s):
2016 ◽
Vol 5
(2)
◽
pp. 59-66
◽
Keyword(s):
2015 ◽
Keyword(s):
Keyword(s):